1.Application of full-neuroendoscopic technique in surgical treatment of posterior cranial fossa lesions
Zhiyi ZHOU ; Hao ZHAO ; Yifeng MIAO ; Chihao ZHU ; Xi YANG ; Siyuan WANG ; Junfeng FENG ; Yongming QIU
Journal of Shanghai Jiaotong University(Medical Science) 2025;45(3):365-372
Objective·To investigate the application effects and benefits of full-neuroendoscopic technique in the surgical treatment of posterior cranial fossa lesions.Methods·A retrospective analysis was conducted on the clinical data of 105 patients with posterior cranial fossa lesions who underwent surgery using full-neuroendoscopic techniques at the Department of Neurosurgery,Renji Hospital,Shanghai Jiao Tong University School of Medicine,between January 2021 and December 2023.The data included patients'gender,age,lesion locations,nature of lesions,surgical procedures,and postoperative recovery.Follow-up with contrast-enhanced MRI was performed one month postoperatively,with subsequent follow-ups every three months on average,depending on the nature of the lesions.Results·Among the 105 patients,there were 45 males with an average age of(56±17)years and 60 females with an average age of(62±12)years.Lesions were predominantly located in the cerebellopontine angle area(78 cases),with others in the petrous bone area(7 cases),cerebellum(10 cases),and brainstem(10 cases).The nature of lesions included vestibular schwannoma(11 cases),meningioma(7 cases),glioma(7 cases),brain metastases(7 cases),hemangioblastoma(6 cases),cyst(1 case),and neuropathic conditions such as trigeminal neuralgia(43 cases),hemifacial spasm(22 cases),and glossopharyngeal neuralgia(1 case).All patients successfully underwent resection or biopsy of their lesions or microvascular decompression under full-neuroendoscopy.The follow-up period ranged from 3 months to 3 years.Enhanced MRI confirmed complete resection in 34 tumor cases(87.2%),near-total resection in 3 cases(7.7%),and biopsy in 2 cases(5.1%).Three deaths occurred during follow-up.Among the patients with vascular neuropathic diseases,two with trigeminal neuralgia experienced incomplete pain relief postoperatively.The resolution rates for hemifacial spasm and glossopharyngeal neuralgia were 100%.Postoperative complications occurred in 3 cases,with 2 cases of hydrocephalus that were managed with ventriculoperitoneal shunting,and 1 case of poor wound healing.Conclusion·Full-neuroendoscopic technique demonstrates potential in the surgical treatment of posterior cranial fossa lesions.
2.Application of full-neuroendoscopic technique in surgical treatment of posterior cranial fossa lesions
Zhiyi ZHOU ; Hao ZHAO ; Yifeng MIAO ; Chihao ZHU ; Xi YANG ; Siyuan WANG ; Junfeng FENG ; Yongming QIU
Journal of Shanghai Jiaotong University(Medical Science) 2025;45(3):365-372
Objective·To investigate the application effects and benefits of full-neuroendoscopic technique in the surgical treatment of posterior cranial fossa lesions.Methods·A retrospective analysis was conducted on the clinical data of 105 patients with posterior cranial fossa lesions who underwent surgery using full-neuroendoscopic techniques at the Department of Neurosurgery,Renji Hospital,Shanghai Jiao Tong University School of Medicine,between January 2021 and December 2023.The data included patients'gender,age,lesion locations,nature of lesions,surgical procedures,and postoperative recovery.Follow-up with contrast-enhanced MRI was performed one month postoperatively,with subsequent follow-ups every three months on average,depending on the nature of the lesions.Results·Among the 105 patients,there were 45 males with an average age of(56±17)years and 60 females with an average age of(62±12)years.Lesions were predominantly located in the cerebellopontine angle area(78 cases),with others in the petrous bone area(7 cases),cerebellum(10 cases),and brainstem(10 cases).The nature of lesions included vestibular schwannoma(11 cases),meningioma(7 cases),glioma(7 cases),brain metastases(7 cases),hemangioblastoma(6 cases),cyst(1 case),and neuropathic conditions such as trigeminal neuralgia(43 cases),hemifacial spasm(22 cases),and glossopharyngeal neuralgia(1 case).All patients successfully underwent resection or biopsy of their lesions or microvascular decompression under full-neuroendoscopy.The follow-up period ranged from 3 months to 3 years.Enhanced MRI confirmed complete resection in 34 tumor cases(87.2%),near-total resection in 3 cases(7.7%),and biopsy in 2 cases(5.1%).Three deaths occurred during follow-up.Among the patients with vascular neuropathic diseases,two with trigeminal neuralgia experienced incomplete pain relief postoperatively.The resolution rates for hemifacial spasm and glossopharyngeal neuralgia were 100%.Postoperative complications occurred in 3 cases,with 2 cases of hydrocephalus that were managed with ventriculoperitoneal shunting,and 1 case of poor wound healing.Conclusion·Full-neuroendoscopic technique demonstrates potential in the surgical treatment of posterior cranial fossa lesions.
3.miR-181b functions as an oncomiR in colorectal cancer by targeting PDCD4.
Yanqing LIU ; UZAIR-UR-REHMAN ; Yu GUO ; Hongwei LIANG ; Rongjie CHENG ; Fei YANG ; Yeting HONG ; Chihao ZHAO ; Minghui LIU ; Mengchao YU ; Xinyan ZHOU ; Kai YIN ; Jiangning CHEN ; Junfeng ZHANG ; Chen-Yu ZHANG ; Feng ZHI ; Xi CHEN
Protein & Cell 2016;7(10):722-734
Programmed cell death 4 (PDCD4) is a RNA-binding protein that acts as a tumor suppressor in many cancer types, including colorectal cancer (CRC). During CRC carcinogenesis, PDCD4 protein levels remarkably decrease, but the underlying molecular mechanism for decreased PDCD4 expression is not fully understood. In this study, we performed bioinformatics analysis to identify miRNAs that potentially target PDCD4. We demonstrated miR-181b as a direct regulator of PDCD4. We further showed that activation of IL6/STAT3 signaling pathway increased miR-181b expression and consequently resulted in downregulation of PDCD4 in CRC cells. In addition, we investigated the biological effects of PDCD4 inhibition by miR-181b both in vitro and in vivo and found that miR-181b could promote cell proliferation and migration and suppress apoptosis in CRC cells and accelerate tumor growth in xenograft mice, potentially through targeting PDCD4. Taken together, this study highlights an oncomiR role for miR-181b in regulating PDCD4 in CRC and suggests that miR-181b may be a novel molecular therapeutic target for CRC.
Animals
;
Apoptosis Regulatory Proteins
;
genetics
;
metabolism
;
Caco-2 Cells
;
Cell Proliferation
;
Colorectal Neoplasms
;
genetics
;
metabolism
;
pathology
;
Heterografts
;
Humans
;
Male
;
Mice
;
Mice, Nude
;
Mice, SCID
;
MicroRNAs
;
genetics
;
metabolism
;
Neoplasm Proteins
;
genetics
;
metabolism
;
Neoplasm Transplantation
;
RNA, Neoplasm
;
genetics
;
metabolism
;
RNA-Binding Proteins
;
genetics
;
metabolism

Result Analysis
Print
Save
E-mail